BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abou Rached A, Yaghi C, Khalil L, Saba J, Ammar W. Prevalence of hepatitis C virus genotypes and subtypes in Lebanese population and major high risk groups. Arab J Gastroenterol 2017;18:114-7. [PMID: 28579342 DOI: 10.1016/j.ajg.2017.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Abou Rached A, Saba J, Yaghi C, Sharara A, Ammar W. Real World Experience with All-Oral Interferon Free Regimen for the Treatment of Lebanese Patients with Hepatitis C Virus (HCV) Infection. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.69040] [Reference Citation Analysis]
2 Nasser SC, Mansour H, Abi Nader T, Metni M. Cost-effectiveness of novel treatment of hepatitis C virus in Lebanese patients. Int J Clin Pharm 2018;40:693-9. [PMID: 29611014 DOI: 10.1007/s11096-018-0628-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]